Blood Cell Separation Market Size to be USD 14.4 Billion by 2035; Rising Incidence of Chronic Diseases Boosts Market Expansion

Download Sample

Published Date: April 2025

Blood separation is the process of dividing whole blood into components such as plasma platelets and red blood cells for diagnostic and therapeutic purposes. This process is crucial for personalized medicine, biopharmaceutical developments, stem cell therapy, cancer research, and more. The blood cell separation market growth is driven by its effectiveness, improved diagnosis, and improved patient outcomes.

Segmentation Analysis:

By Product	Consumables and Instruments
By Cell Type	Human Cells, Animal Cells, and Others
By Technique	Centrifugation-based Cell Isolation, Surface marker-based Cell Isolation, and Filtration-based Cell Isolation
By Application	Biomolecule Isolation, Cancer Research, Stem Cell Research, In-vitro Diagnostics, and Others
By End-User	Research Laboratories and Institutes, Hospitals, and Others

Report Highlights:

Blood cell separation market size is valuated at USD 7.6 Billion in 2025.
Target market size is anticipated to reach a USD 14.4 Billion valuation by 2035 and at a CAGR of 7.2%.
Based on product, the consumables segment is attributed to lead the blood cell separation market.
By cell type, the human cell type is dominating the blood cell separation market.
On the basis of technique, the centrifugation-based cell isolation is expected to dominate the market.
According to application, the biomolecule isolation segment holds the largest blood cell separation market share.
Under end-user, the market is being dominated by the research laboratories and institutes segment.
North America is the region, which is leading the blood cell separation market in terms of share.
Europe is the region where the blood cell separation market grows with the highest CAGR during the forecast period.

Market Dynamics:

Growing Factor	Challenge Factor	Market Trend
Growing Demand for Biopharmaceuticals and Personalized Medicine	Potential Cell Damage Caused by Blood Cell Separation	Integration of Advanced Technologies with Blood Cell Separation

Key Highlights:

In October 2024, Terumo Blood and Cell Technologies, a global leader in blood management solutions, had launched the Reveos Automated Blood Processing System in the U.S., to help blood centers meet blood and platelet supply needs while helping its staff work more efficiently. Carter BloodCare in Texas was getting ready to implement Reveos to manufacture platelets, red blood cells and plasma for transfusion.

Report Analysis:

Complex Biological Samples on which Cell Separation is Performed:

Whole peripheral blood
Leukapheresis products (e.g. Leukopaks)
Peripheral blood mononuclear cells (PBMCs)
Bone marrow
Cord blood

Browse ∼60 market data tables and ∼35 figures through ∼160 slides and in-depth TOC on “Blood Cell Separation Market, By Product (Consumables, and Instruments), Cell Type (Human Cells, Animal Cells, and Others), Technique (Centrifugation-based Cell Isolation, Surface marker-based Cell Isolation, and Filtration-based Cell Isolation), Application (Biomolecule Isolation, Cancer Research, Stem Cell Research, In-vitro Diagnostics, and Others), End-User (Research Laboratories and Institutes, Hospitals, and Others), and Region - Trends, Analysis, and Forecast till 2034”

Segmentation:

By Product:

Consumables
Instruments

By Cell Type:

Human Cells
Animal Cells
Others

By Technique:

Centrifugation-based Cell Isolation
Surface marker-based Cell Isolation
Filtration-based Cell Isolation

By Application:

Biomolecule Isolation
Cancer Research
Stem Cell Research
In-vitro Diagnostics
Others

By End User:

Research Laboratories and Institutes
Hospitals
Others

By Region:

North America
- U.S.
- Canada
Europe
- Germany
- U.K.
- France
- Russia
- Italy
- Spain
- Netherlands
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- Indonesia
- Malaysia
- South Korea
- Rest of Asia Pacific
Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of the Middle East & Africa

For more insights into the Blood Cell Separation Market and its future trends, visit link below: https://www.prophecymarketinsights.com/market_insight/blood-cell-separation-market-4561

Competitive Landscape of Blood Cell Separation Market:

The companies operating in this market are BD, TERUMO BCT, INC., STEMCELL Technologies, Bio-Rad Laboratories, Inc., Beckman Coulter, Inc., Merck KGaA, Thermo Fisher Scientific Inc., pluriSelect USA, Miltenyi Biotec, Fortis Life Sciences, IBM, Akadeum Life Sciences, and REPROCELL Inc.